TORONTO , Aug. 8, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF ) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended June 30, 2024 , before markets open on Wednesday, August 14, 2024 .
MediPharm Labs executive management team will also host a conference call and audio webcast on Wednesday, August 14, 2024 , at 8:30 a.m. (Eastern time) to discuss the Company's financial results.
Audio Conference Call Dial in Details: North America Toll-Free : (888) 330-2454 International Toll: +1(240) 789-2714 Conference ID: 4921762 Participants are asked to dial in approximately 15 minutes before the start of the call. Audio Webcast: An audio webcast will be available by visiting the following link here . For those who are unable to participate on the live conference call or webcast, a replay will be available at https://www.
medipharmlabs.com/investors approximately one day after completion of the call. About MediPharm Labs Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms.
MediPharm Labs has invested in an expert, research driven team, state-of-t.